Provided by Tiger Fintech (Singapore) Pte. Ltd.

Spero Therapeutics Inc.

0.7542
+0.01421.92%
Post-market: 0.75420.00000.00%17:33 EDT
Volume:35.94K
Turnover:27.62K
Market Cap:42.16M
PE:-0.59
High:0.7860
Open:0.7400
Low:0.7400
Close:0.7400
Loading ...
Oct 12, 2021

Major Issues Report

8-K - Current report
Sep 30, 2021

Major Issues Report

8-K - Current report
Sep 20, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 16, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 30, 2021

Major Issues Report

8-K - Current report
Aug 18, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 01, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Mar 24, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 23, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals